These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Development of new antidepressants. Sambunaris A, Hesselink JK, Pinder R, Panagides J, Stahl SM. J Clin Psychiatry; 1997; 58 Suppl 6():40-53. PubMed ID: 9227672 [Abstract] [Full Text] [Related]
23. A case report of serotonin syndrome associated with combined nefazodone and fluoxetine. Smith DL, Wenegrat BG. J Clin Psychiatry; 2000 Feb; 61(2):146. PubMed ID: 10732666 [No Abstract] [Full Text] [Related]
24. [Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)]. Ansseau M. Rev Med Liege; 1998 Feb; 53(2):106-8. PubMed ID: 9564231 [Abstract] [Full Text] [Related]
25. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. Asarnow JR, Emslie G, Clarke G, Wagner KD, Spirito A, Vitiello B, Iyengar S, Shamseddeen W, Ritz L, Birmaher B, Ryan N, Kennard B, Mayes T, DeBar L, McCracken J, Strober M, Suddath R, Leonard H, Porta G, Keller M, Brent D. J Am Acad Child Adolesc Psychiatry; 2009 Mar; 48(3):330-339. PubMed ID: 19182688 [Abstract] [Full Text] [Related]
26. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B. Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923 [Abstract] [Full Text] [Related]
27. Severe hypertriglyceridemia secondary to venlafaxine and fluoxetine. Teitelbaum M. Psychosomatics; 2001 Nov; 42(5):440-1. PubMed ID: 11739916 [No Abstract] [Full Text] [Related]
28. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. Preskorn SH. J Clin Psychiatry; 1995 Nov; 56 Suppl 6():12-21. PubMed ID: 7649968 [Abstract] [Full Text] [Related]
29. Antidepressant discontinuation: a review of the literature. Lejoyeux M, Adès J. J Clin Psychiatry; 1997 Nov; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488 [Abstract] [Full Text] [Related]
30. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine. Masand PS, Gupta S. Ann Clin Psychiatry; 2002 Sep; 14(3):175-82. PubMed ID: 12585567 [Abstract] [Full Text] [Related]
31. Nefazodone and venlafaxine: two new agents for the treatment of depression. Goldberg RJ. J Fam Pract; 1995 Dec; 41(6):591-4. PubMed ID: 7500069 [Abstract] [Full Text] [Related]
32. Serotonin syndrome: a complex but easily avoidable condition. Dvir Y, Smallwood P. Gen Hosp Psychiatry; 2008 Dec; 30(3):284-7. PubMed ID: 18433663 [Abstract] [Full Text] [Related]
33. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis. Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N. Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525 [Abstract] [Full Text] [Related]